Literature DB >> 26440786

Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection.

Romain Olekhnovitch1, Philippe Bousso2.   

Abstract

The production of nitric oxide (NO) by the inducible NO synthase (iNOS) is a key defense mechanism against intracellular pathogens such as Leishmania. Numerous studies have investigated the antimicrobial properties of this small molecule in vitro but its precise mode of action during Leishmania infection in vivo is still unclear. In this review, we discuss how iNOS is induced in infected tissues and how NO acts to control the expansion of Leishmania parasites and limit tissue damage resulting from the infection. We highlight recently described mechanisms that result in widespread iNOS expression in infected tissues. We also discuss how the collective production and subsequent diffusion of NO generates an antimicrobial milieu that promotes parasite control at the tissue level.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Leishmania; T cell; antimicrobial activity; immunopathology; nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 26440786     DOI: 10.1016/j.pt.2015.08.001

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  24 in total

1.  A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.

Authors:  Daniela P Lage; Patrícia A F Ribeiro; Daniel S Dias; Débora V C Mendonça; Fernanda F Ramos; Lívia M Carvalho; Daysiane de Oliveira; Bethina T Steiner; Vívian T Martins; Luísa Perin; Amanda S Machado; Thaís T O Santos; Grasiele S V Tavares; João A Oliveira-da-Silva; Jamil S Oliveira; Bruno M Roatt; Ricardo A Machado-de-Ávila; Antônio L Teixeira; Maria V Humbert; Eduardo A F Coelho; Myron Christodoulides
Journal:  NPJ Vaccines       Date:  2020-08-13       Impact factor: 7.344

2.  Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

3.  Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.

Authors:  Valentin Schatz; Yannic Strüssmann; Alexander Mahnke; Gunnar Schley; Maximilian Waldner; Uwe Ritter; Jens Wild; Carsten Willam; Nathalie Dehne; Bernhard Brüne; Jennifer M McNiff; Oscar R Colegio; Christian Bogdan; Jonathan Jantsch
Journal:  J Immunol       Date:  2016-10-17       Impact factor: 5.422

Review 4.  IFN-induced cell-autonomous immune mechanisms in the control of intracellular protozoa.

Authors:  Sini Skariah; Ali A Sultan; Dana G Mordue
Journal:  Parasitol Res       Date:  2022-04-18       Impact factor: 2.383

5.  Leishmania infantum Parasites Subvert the Host Inflammatory Response through the Adenosine A2A Receptor to Promote the Establishment of Infection.

Authors:  Mikhael H F Lima; Lais A Sacramento; Gustavo F S Quirino; Marcela D Ferreira; Luciana Benevides; Alynne K M Santana; Fernando Q Cunha; Roque P Almeida; João S Silva; Vanessa Carregaro
Journal:  Front Immunol       Date:  2017-07-20       Impact factor: 7.561

6.  Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.

Authors:  Alireza Badirzadeh; Tahereh Taheri; Yasaman Taslimi; Zahra Abdossamadi; Maryam Heidari-Kharaji; Elham Gholami; Baharehsadat Sedaghat; Maryam Niyyati; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

Review 7.  Hypoxia, Hypoxia-Inducible Factor-1α, and Innate Antileishmanial Immune Responses.

Authors:  Valentin Schatz; Patrick Neubert; Franz Rieger; Jonathan Jantsch
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

8.  Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2.

Authors:  Jonilson Berlink Lima; Théo Araújo-Santos; Milena Lázaro-Souza; Alan Brito Carneiro; Izabela Coimbra Ibraim; Flávio Henrique Jesus-Santos; Nívea Farias Luz; Sara de Moura Pontes; Petter Franco Entringer; Albert Descoteaux; Patrícia Torres Bozza; Rodrigo Pedro Soares; Valéria Matos Borges
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

9.  Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection.

Authors:  Laís A Sacramento; Jéssica L da Costa; Mikhael H F de Lima; Pedro A Sampaio; Roque P Almeida; Fernando Q Cunha; João S Silva; Vanessa Carregaro
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

10.  Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.

Authors:  Daniela P Lage; Patrícia A F Ribeiro; Daniel S Dias; Débora V C Mendonça; Fernanda F Ramos; Lívia M Carvalho; Bethina T Steiner; Grasiele S V Tavares; Vívian T Martins; Amanda S Machado; João A Oliveira-da-Silva; Thaís T O Santos; Camila S Freitas; Jamil S Oliveira; Bruno M Roatt; Ricardo A Machado-de-Ávila; Maria V Humbert; Myron Christodoulides; Eduardo A F Coelho
Journal:  Vaccines (Basel)       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.